| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 06/20/2001 | EP1107971A1 Porphyrin derivatives, their use in photodynamic therapy and medical devices containing them |
| 06/20/2001 | EP1107962A1 Quinolin-2-one derivatives useful as anticancer agents |
| 06/20/2001 | EP1107960A1 Pyrazine compounds |
| 06/20/2001 | EP1107957A1 Pyrimidine compounds |
| 06/20/2001 | EP1107953A1 Hydroxamic acid derivatives as proteinase inhibitors |
| 06/20/2001 | EP1107780A2 Selective treatment of endothelial somatostatin receptors |
| 06/20/2001 | EP1107758A2 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase |
| 06/20/2001 | EP1107755A1 N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders |
| 06/20/2001 | EP1107754A1 Ureas and carbamates of n-heterocyclic carboxylic acids and isosteres for vision and memory disorders |
| 06/20/2001 | EP1107753A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 06/20/2001 | EP1107752A1 Pyrrolidine derivatives for vision and memory disorders |
| 06/20/2001 | EP1107731A1 Synthetic tear fluid |
| 06/20/2001 | CN1299646A Application of venoruton in treating cataract |
| 06/19/2001 | US6248901 Heterocyclic vinyl ethers |
| 06/19/2001 | US6248867 Polypeptide associated with proper eye function; for the diagnosis of vision defects |
| 06/19/2001 | US6248783 Cyclopentane 1-hydroxy alkyl or alkenyl-2-one or 2-hydroxy derivatives as therapeutic agents |
| 06/19/2001 | US6248773 Vision defects |
| 06/19/2001 | US6248765 Imidazole derivatives as histamine receptor H3 (ANT) agonists |
| 06/19/2001 | US6248759 Administering a dihydropyridine calcium antagonist |
| 06/19/2001 | US6248755 Antiinflammatory agents; antiallergens; autoimmune diseases |
| 06/19/2001 | US6248741 Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury |
| 06/19/2001 | US6248734 Use of photodynamic therapy for prevention of secondary cataracts |
| 06/19/2001 | US6248594 Kinesin-like motor protein |
| 06/19/2001 | US6248557 RatC |
| 06/19/2001 | US6248308 Methods of using norastemizole in combination with leukotriene inhibitors to treat or prevent asthma |
| 06/19/2001 | CA2190973C Novel 4,6-diarylpyrimidine derivatives and salts thereof |
| 06/19/2001 | CA2125964C Imidazolyl-alkyl-piperazine and -diazepine derivatives as histamine h3 agonists/antagonists |
| 06/14/2001 | WO2001042471A2 Polypeptides and polynucleotides encoding same |
| 06/14/2001 | WO2001042459A1 Apoptosis inhibitory polypeptide, gene and polynucleotide encoding it and compositions containing the same |
| 06/14/2001 | WO2001042305A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | WO2001042288A2 G-protein coupled receptors |
| 06/14/2001 | WO2001042273A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 06/14/2001 | WO2001042238A1 Heterocyclic derivatives |
| 06/14/2001 | WO2001042222A1 Polymorphic crystalline forms of celecoxib |
| 06/14/2001 | WO2001042221A1 Solid-state form of celecoxib having enhanced bioavailability |
| 06/14/2001 | WO2001042216A2 Caspase inhibitors and uses thereof |
| 06/14/2001 | WO2001042213A1 Urea compounds having muscarinic receptor antagonist activity |
| 06/14/2001 | WO2001042212A1 Carbamate derivatives having muscarinic receptor antagonist activity |
| 06/14/2001 | WO2001042192A2 Vla-4 integrin antagonists |
| 06/14/2001 | WO2001042191A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy |
| 06/14/2001 | WO2001041792A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | WO2001041762A2 Valdecoxib compositions |
| 06/14/2001 | WO2001041761A2 Valdecoxib compositions |
| 06/14/2001 | WO2001041760A2 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 06/14/2001 | WO2001041536A2 Solid-state form of celecoxib having enhanced bioavailability |
| 06/14/2001 | WO2001027101A3 Anhydrous salt |
| 06/14/2001 | WO2001018040A3 Use of leptin in inhibition of endothelial cell proliferation |
| 06/14/2001 | WO2001017989A3 Heteroaryloxypropanolamines as beta3-adrenergic receptor agonists |
| 06/14/2001 | WO2001009113A3 Heterocyclic compounds inhibiting angiogenesis |
| 06/14/2001 | WO2001007022A3 Azetidine compounds in cns and eye diseases |
| 06/14/2001 | WO2001003720A3 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 06/14/2001 | WO2000068267A9 LOW-DOSE IL-1β-INDUCED PHOTORECEPTOR CELL RESCUE WITHOUT RETINAL DYSPLASIA |
| 06/14/2001 | WO2000032631A3 Proteins that bind angiogenesis-inhibiting proteins, compositions and methods of use thereof |
| 06/14/2001 | CA2733434A1 Caspase inhibitors and uses thereof |
| 06/14/2001 | CA2394917A1 Polypeptides and polynucleotides encoding same |
| 06/14/2001 | CA2393661A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | CA2393532A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | CA2392961A1 G-protein coupled receptors |
| 06/14/2001 | CA2388686A1 Vla-4 integrin antagonists |
| 06/14/2001 | CA2362815A1 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 06/14/2001 | CA2362675A1 Polymorphic crystalline forms of celecoxib |
| 06/14/2001 | CA2361647A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy |
| 06/13/2001 | EP1106615A1 Substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/13/2001 | EP1106614A1 5-Membered heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/13/2001 | EP1106210A2 Combination of aldose reductase inhibitors and antihypertensive agents for the treatment of diabetic complications |
| 06/13/2001 | EP1106184A2 Combination of aldose reductase inhibitors and selective serotonin reuptake inhibitors for the treatment of diabetic complications |
| 06/13/2001 | EP1105478A1 Extracellular adhesive proteins, exadh1 and exadh2 |
| 06/13/2001 | EP1105421A2 Anti-inflammatory peptides derived from il-2 and analogues thereof |
| 06/13/2001 | EP1105420A1 Cyclic prosaposin-derived peptides and uses thereof |
| 06/13/2001 | EP1105389A1 Integrin receptor antagonists |
| 06/13/2001 | EP1105384A1 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors |
| 06/13/2001 | EP1105371A2 Novel aryl sulphonamide amino acid esters and analogues |
| 06/13/2001 | EP1105370A1 Novel aryl sulphonamides and analogues |
| 06/13/2001 | EP1105139A1 Ophthalmic solution with tetracycline for topical treatment of dry eye disease |
| 06/13/2001 | EP1105136A2 Method for treating ocular neovascular diseases |
| 06/13/2001 | EP1105131A2 Small molecule carbamates or ureas for vision and memory disorders |
| 06/13/2001 | EP1105130A2 Heterocyclic esters or amides for vision and memory disorders |
| 06/13/2001 | EP1105128A2 Carboxylic acids and isosteres of n-heterocyclic compounds for vision and memory disorders |
| 06/13/2001 | EP1105126A2 Sulfonamides of n-containing heterocyclic thioesters for vision and memory disorders |
| 06/13/2001 | EP1105125A2 Use of sulfonamides for treating vision and memory disorders |
| 06/13/2001 | EP1105124A2 N-linked sulfonamides of n-heterocyclic carboxylic acids or isosteres for vision and memory disorders |
| 06/13/2001 | EP1105112A2 Compositions and uses for vision and memory disorders |
| 06/13/2001 | EP0805858B1 Inhibition of neovascularization using vegf-specific oligonucleotides |
| 06/13/2001 | CN1299342A Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents |
| 06/13/2001 | CN1299257A Use of corneal hardening agent in enzyme orthokeratology |
| 06/13/2001 | CN1298721A Cassia seed tea and its preparing process |
| 06/13/2001 | CN1298706A Kelarmycin eye drops and its preparing process |
| 06/13/2001 | CN1067054C 1H-indole-3-glyoxylamide 5 PLA 2 inhibitors |
| 06/13/2001 | CN1066946C Eyesight improving liquid for curing shortsightedness by fumigation |
| 06/13/2001 | CN1066945C Chinese medicine for improving eyesight and its prodn. method |
| 06/12/2001 | US6245820 Method for treating Meniere's disease |
| 06/12/2001 | US6245811 Fatty acid esters as bioactive compounds |
| 06/12/2001 | US6245759 Tyrosine kinase inhibitors |
| 06/12/2001 | US6245544 An isolated polypeptide having a specific amino acid sequence; antiproliferative, anticarcinogenic, antitumor, antiarthritic, antiinflammatory agents; metastatsis; psoriasis; vision defects |
| 06/12/2001 | US6245338 OMP26 antigen from Haemophilus influenzae |
| 06/11/2001 | WO2001044230A1 1-(aminophenyl)-2-pyrrolidones as integrin inhibitors |
| 06/11/2001 | CA2393310A1 1-(aminophenyl)-2-pyrrolidones as integrin inhibitors |
| 06/10/2001 | CA2327946A1 Substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/10/2001 | CA2327925A1 5-membered heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/07/2001 | WO2001040519A2 Methods for identifying modulators for balance related disorders |